Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 155 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes MOST POPULAR Pastor Opens Homeless Shelter And Moves In To Raise Money For... December 29, 2021 FDA Approves Gemtuzumab Ozogamicin for CD33-positive AML in Paediatric Patients June 23, 2020 POT1 Mutations Associated with Long Telomere Length Confer a Predisposition to... May 17, 2023 Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors? June 20, 2018 Load more HOT NEWS Navigating Life During and After Cancer As a Young Adult: A... Fruquintinib Prolongs Survival Compared with Placebo in Heavily Pretreated Patients with... Second Interim Analysis Shows OS Improvement with Adjuvant Olaparib for Germline... How I Learned to Advocate for Myself During Cancer: “Your Stories”...
